专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

21. 发明授权

US07435304B2 Coating composition, and method for manufacturing high silicon electrical steel sheet using thereof 有权
标题翻译：涂料组合物及使用其制造高硅电工钢板的方法
公开(公告)号：US07435304B2
公开(公告)日：2008-10-14
申请号：US10519227
申请日：2003-11-11
申请人： Kyu-Seung Choi , Jong-Soo Woo
发明人： Kyu-Seung Choi , Jong-Soo Woo
IPC分类号： H01F1/16 , C09D1/00
CPC分类号： C21D8/1277 , C21D8/1244 , C21D8/1266 , C23C10/02 , C23C10/20 , C23C10/30
摘要： There are provided a coating composition for siliconizing, and a method for manufacturing a high silicon electrical steel sheet using the same. The coating composition includes: a Fe—Si-based composite compound sintered powder having a grain size of −325 mesh and containing 20-70% silicon by weight; and a colloidal silica solution containing 15-30 part by weight of silica solid matter with respect to 100 part by weight of the sintered powder.
摘要翻译：提供了用于硅化的涂料组合物，以及使用其的高硅电工钢板的制造方法。涂料组合物包括：粒径为-325目并含有20-70重量％硅的Fe-Si基复合化合物烧结粉末; 和相对于烧结粉末100重量份含有15-30重量份二氧化硅固体物质的胶体二氧化硅溶液。

22. 发明申请

US20060062810A1 Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same 审中-公开
标题翻译：用于口服非水溶性抗冷药物的微乳液浓缩物及其制备方法
公开(公告)号：US20060062810A1
公开(公告)日：2006-03-23
申请号：US10534066
申请日：2003-11-07
申请人： Jong-Soo Woo , Ae-Guk Kim
发明人： Jong-Soo Woo , Ae-Guk Kim
IPC分类号： A61K31/192 , A61K31/137 , A61K9/00
CPC分类号： A61K9/1075 , A61K31/137 , A61K31/192 , A61K47/10 , A61K47/26
摘要： A microemulsion concentrate comprising a water-insoluble anti-cold drug, a surfactant and an oil, which is prepared by a method comprising: (a) dissolving the water-insoluble anti-cold drug in a co-surfactant to obtain a homogeneous drug solution; (b) adding the surfactant and the oil in the drug solution to obtain a microemulsion pre-concentrate; and (c) removing the co-surfactant from the pre-concentrate, contains emulsified drug microparticles which are stable toward pH change and therefore, provides improved bioavaiability of the drug when orally administered.
摘要翻译：一种微乳液浓缩物，其包含水不溶性抗冷药物，表面活性剂和油，其通过以下方法制备，所述方法包括：（a）将所述水不溶性抗冷药物溶解在辅助表面活性剂中以获得均匀的药物溶液 ; （b）在药液中加入表面活性剂和油，得到预浓缩微乳液; 和（c）从预浓缩物中除去辅助表面活性剂包含对pH变化稳定的乳化药物微粒，因此，当口服时提供药物的改善的生物可消毒性。

23. 发明授权

US06451128B1 Method for manufacturing high magnetic flux denshy grain oriented electrical steel sheet based on low temperature slab heating method 有权
标题翻译：基于低温板坯加热方法制造高磁通密度晶粒取向电工钢板的方法
公开(公告)号：US06451128B1
公开(公告)日：2002-09-17
申请号：US09242865
申请日：1999-02-25
申请人： Chung San Lee , Chan Hye Han , Jong Soo Woo , Gyu Seung Choi , Jae Kwan Kim , Byung Deuk Hong , Kyu Seok Han
发明人： Chung San Lee , Chan Hye Han , Jong Soo Woo , Gyu Seung Choi , Jae Kwan Kim , Byung Deuk Hong , Kyu Seok Han
IPC分类号： H01F1147
CPC分类号： C21D3/04 , C21D8/1255 , C21D8/1272
摘要： A method for manufacturing a high magnetic flux density grain oriented electrical steel sheet is disclosed. A silicon steel slab is heated and hot-rolled, and the steel sheet is annealed and cold-rolled and decarburized. An annealing separator is spread on the steel sheet, and a final high temperature annealing is carried out. The silicon steel contains in weight % 0.02-0.045% of C, 2.90-3.30% of Si, 0.05-0.30% of Mn, 0.005-0.019% of Al, 0.003-0.008% of N, 0.006% or less of S (the above being main ingredients), 0.001-0.012% of B, and a balance of Fe and unavoidable impurities; or the above main ingredients plus 0.30-0.70% of Cu, 0.03-0.07% of Ni, 0.03-0.07% of Cr, and a balance of Fe and unavoidable impurities; or the above main ingredients plus 0.001-0.012% of B, 0.30-0.70% of Cu, 0.03-0.07% of Ni, 0.03-0.07% of Cr, and a balance of Fe and unavoidable impurities.
摘要翻译：公开了一种制造高磁通密度晶粒取向电工钢板的方法。对硅钢板进行加热热轧，对钢板进行退火冷轧，脱碳。将退火分离器铺展在钢板上，进行最终的高温退火。硅钢的重量％为C：0.02-0.045％，Si：2.90-3.30％，Mn：0.05-0.30％，Al：0.005-0.019％，N：0.003-0.008％，S：0.006％以上为主要成分），0.001-0.012％B，余量为Fe和不可避免的杂质; 或上述主要成分加入Cu 0.30-0.70％，Ni 0.03-0.07％，Cr 0.03-0.07％，余量为Fe和不可避免的杂质; 或上述主要成分加上0.001-0.012％的B，0.30-0.70％的Cu，0.03-0.07％的Ni，0.03-0.07％的Cr，余量的Fe和不可避免的杂质。

24. 发明授权

US6107290A Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof 失效
标题翻译：非结晶头孢呋辛酯固体分散剂，其制备方法和口服给药组合物
公开(公告)号：US6107290A
公开(公告)日：2000-08-22
申请号：US397745
申请日：1999-09-16
申请人： Jong-Soo Woo , Hee-Chul Chang
发明人： Jong-Soo Woo , Hee-Chul Chang
IPC分类号： A61K9/00 , A61K9/10 , A61K9/16 , A61K31/545 , A61K31/546 , A61K47/00 , A61P31/04 , C07D501/00
CPC分类号： A61K31/546 , A61K9/1611 , A61K9/1617 , A61K9/1641
摘要： A non-crystalline cefuroxime axetil solid dispersant showing no absorption peak on a Differential Scanning Calorimetry scan is prepared by (a) dissolving cefuroxime axetil and a surfactant in an organic solvent; (b) suspending a water-insoluble inorganic carrier in the resulting solution; and (c) drying the resulting suspension to remove the organic solvent, said solid dispersant having an improved bioavailability and stability of cefuroxime axetil and being useful for the preparation of a pharmaceutical composition for oral administration.
摘要翻译：通过（a）将头孢呋辛酯和表面活性剂溶解在有机溶剂中，制备在差示扫描量热扫描中不显示吸收峰的非结晶头孢呋辛酯固体分散剂; （b）在所得溶液中悬浮水不溶性无机载体; 和（c）干燥所得悬浮液以除去有机溶剂，所述固体分散剂具有改善的头孢呋辛酯酯的生物利用度和稳定性，并且可用于制备用于口服给药的药物组合物。

25. 发明授权

US6039981A Antifungal oral composition containing itraconazole and process for preparing same 失效
标题翻译：含有伊曲康唑的抗真菌口服组合物及其制备方法
公开(公告)号：US6039981A
公开(公告)日：2000-03-21
申请号：US411510
申请日：1999-10-04
申请人： Jong-Soo Woo , Hong-Gi Yi
发明人： Jong-Soo Woo , Hong-Gi Yi
IPC分类号： A61K9/48 , A61K9/14 , A61K9/50 , A61K31/40 , A61K31/4196 , A61K31/495 , A61K31/496 , A61K33/42 , A61K47/02 , A61K47/04 , A61K47/14 , A61K47/20 , A61K47/24 , A61K47/26 , A61K47/34 , A61K47/36 , A61K47/38 , A61K47/44 , A61P31/10
CPC分类号： A61K9/143 , A61K31/40 , A61K9/145 , A61K9/146 , A61K9/485 , A61K9/4858 , A61K9/4866 , A61K9/5078
摘要： An antifungal oral composition comprising a fused mixture of itraconazole and phosphoric acid provides a high in vivo bioavailability of itraconazole.
摘要翻译：包含伊曲康唑和磷酸的混合物的抗真菌口服组合物提供伊曲康唑的高体内生物利用度。

26. 发明授权

US5803988A Method for manufacturing non-oriented electrical steel sheet showing superior adherence of insulating coated layer 失效
标题翻译：制造无取向电工钢板的方法，其表现出优异的绝缘涂层粘附性
公开(公告)号：US5803988A
公开(公告)日：1998-09-08
申请号：US894394
申请日：1997-08-18
申请人： Byung Keun Bae , Sam Kyu Chang , Jong Soo Woo , Wun Gul Lee
发明人： Byung Keun Bae , Sam Kyu Chang , Jong Soo Woo , Wun Gul Lee
IPC分类号： C21D3/04 , C21D8/12 , C22C38/02 , H01F1/147 , H01F1/18
CPC分类号： C21D8/1288 , C21D8/1272 , C21D8/1277 , H01F1/147 , H01F1/18 , C21D3/04
摘要： The annealing conditions of a cold rolled steel sheet are properly controlled so as to form a dense surface oxide layer, thereby improving the adherence strength of the insulating layer on non-oriented electrical steel sheet. The method includes the following steps. A steel slab is prepared which is composed of in weight %: 0.05% or less of C, 3.5% or less of Si, 1.5% or less of Mn, 0.15% or less of P, 0.015% or less of S, 1.0% or less of Al, one or more elements selected from a group consisting of 0.03-0.30% of Sn, 0.03-0.3% of Sb, 0.03-1.0% of Ni and 0.03-0.50% of Cu, the balance of Fe and unavoidable impurities. The steel slab is reheated, hot rolled, pickled after annealing or without annealing and cold-rolled. A low temperature annealing is carried out on the cold rolled steel sheet at a temperature of 750.degree.-850.degree. C. for 30 seconds to 5 minutes under a humid atmosphere having a dew point of 25.degree.-65.degree. C. A high temperature annealing is carried out on the low-temperature-annealed cold rolled steel sheet at a temperature of 800.degree.-1070.degree. C. for 10 seconds to 3 minutes under a dry atmosphere having a dew point of 0.degree. C. or below. Insulating layers are coated on the surfaces of the high-temperature-annealed steel sheet, and a hardening heat treatment is carried out on the steel sheet.
摘要翻译： PCT No.PCT / KR96 / 00078 Sec。 371日期：1997年8月18日 102（e）1997年8月18日PCT PCT 1996年6月1日PCT公布。公开号WO97 / 22723 日期1996年6月26日冷轧钢板的退火条件被适当地控制，以形成致密的表面氧化物层，从而提高无取向电工钢板上的绝缘层的粘附强度。该方法包括以下步骤。制备钢板，其重量％：C：0.05％以下，Si：3.5％以下，Mn：1.5％以下，P：0.15％以下，S：0.015％以下，1.0％或更少的Al，一种或多种选自Sn，0.03-0.30％的Sn，0.03-0.3％的Sb，0.03-1.0％的Ni和0.03-0.50％的Cu，其余的Fe和不可避免的杂质。再次加热，热轧，退火或不退火冷轧后酸洗。在露点为25〜-65℃的潮湿气氛下，在750〜-850℃的温度下对冷轧钢板进行低温退火30秒〜5分钟。高温退火在露点为0℃以下的干燥气氛下，在800〜-1070℃的温度下在低温退火冷轧钢板上进行10秒钟〜3分钟。在高温退火钢板的表面上涂布绝缘层，对钢板进行硬化热处理。

27. 发明申请

US20140112962A1 PHARMACEUTICAL COMPOSITION COMPRISING AMIDE DERIVATIVE INHIBITING THE GROWTH OF CANCER CELLS AND NON-METALLIC SALT LUBRICANT 有权
标题翻译：包含酰胺衍生物抑制癌细胞和非金属盐润滑剂生长的药物组合物
公开(公告)号：US20140112962A1
公开(公告)日：2014-04-24
申请号：US14124436
申请日：2012-05-18
申请人： Yong Il Kim , Kyeong Soo Kim , Jin Cheul Kim , Yo Han Kim , Jae Hyun Park , Jong Soo Woo
发明人： Yong Il Kim , Kyeong Soo Kim , Jin Cheul Kim , Yo Han Kim , Jae Hyun Park , Jong Soo Woo
IPC分类号： A61K47/44 , A61K47/26 , A61K47/10 , A61K47/14 , A61K47/02 , A61K47/36 , A61K31/517 , A61K47/12
CPC分类号： A61K47/44 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2031 , A61K9/2077 , A61K31/517 , A61K47/02 , A61K47/06 , A61K47/10 , A61K47/12 , A61K47/14 , A61K47/26 , A61K47/36 , C07D401/12
摘要： Disclosed is a pharmaceutical composition comprising an amide derivative or a pharmaceutically acceptable salt thereof and a non-metallic salt lubricant, which can be used as an effective cancer cell-growth inhibitor owing to its enhanced storage stability with no quality changes over time.
摘要翻译：公开了一种药物组合物，其包含其酰胺衍生物或其药学上可接受的盐和非金属盐润滑剂，其可以用作有效的癌细胞生长抑制剂，这是由于其增强的储存稳定性而随时间而没有质量变化。

28. 发明授权

US08673945B2 Solid pharmaceutical composition comprising amlodipine and losartan 有权
标题翻译：包含氨氯地平和氯沙坦的固体药物组合物
公开(公告)号：US08673945B2
公开(公告)日：2014-03-18
申请号：US13140348
申请日：2009-12-28
申请人： Jong Soo Woo , Jae Hyun Park , Young Il Kim , Kyeong Soo Kim , Ho Taek Yim , Ji Hyun Im
发明人： Jong Soo Woo , Jae Hyun Park , Young Il Kim , Kyeong Soo Kim , Ho Taek Yim , Ji Hyun Im
IPC分类号： A61K31/41 , A61K31/44
CPC分类号： A61K31/41 , A61K9/2013 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K9/2077 , A61K9/5084 , A61K31/4178 , A61K31/44 , A61K31/4422 , A61K2300/00
摘要： The present invention relates to a solid pharmaceutical composition for preventing or treating cardiovascular disorders comprising amlodipine and losartan as active ingredients, and a disintegrant which is a mixture of at least two components selected from the group consisting of sodium starch glycolate, crosscarmellose sodium, and crosspovidone, which exhibits a high and stable level of amlodipine and losartan dissolution rates.
摘要翻译：本发明涉及一种用于预防或治疗包含氨氯地平和氯沙坦作为活性成分的心血管疾病的固体药物组合物，和崩解剂，其是选自淀粉羟乙酸钠，交联羧甲基纤维素钠和交联聚维酮的至少两种组分的混合物，其表现出高且稳定的氨氯地平和氯沙坦溶出速率水平。

29. 发明申请

US20100003289A1 Controlled Release Complex Formulation For Oral Administration of Medicine For Diabetes and Method For The Preparation Thereof 审中-公开
标题翻译：糖尿病口服药物控释制剂及其制备方法
公开(公告)号：US20100003289A1
公开(公告)日：2010-01-07
申请号：US11722560
申请日：2005-12-28
申请人： Jong Soo Woo , Hong Gi Yi , Moon Hyuk Chi , Young Hun Kim
发明人： Jong Soo Woo , Hong Gi Yi , Moon Hyuk Chi , Young Hun Kim
IPC分类号： A61K9/00 , A61K31/155 , A61K31/40 , A61P3/10
CPC分类号： A61K31/155 , A61K9/209 , A61K31/64 , A61K45/06 , A61K2300/00
摘要： A controlled release combination formulation for oral administration comprising a) a controlled release portion containing metformin or a pharmaceutically acceptable salt thereof as an active ingredient, and a combination of a polyethylene oxide and a natural gum as a carrier for controlled release; and b) a rapid-release portion containing a sulfonylurea-based medicine for treating diabetes as an active ingredient coated on the controlled release portion is useful for the treatment of diabetes, for it is capable of maintaining an effective concentration of the medicines in blood at a constant level.
摘要翻译：一种用于口服给药的控释组合制剂，其包含a）含有二甲双胍或其药学上可接受的盐作为活性成分的受控释放部分，以及作为受控释放的载体的聚环氧乙烷和天然树胶的组合; 和b）包含用于治疗糖尿病作为包被在控制释放部分上的活性成分的磺酰脲类药物的快速释放部分可用于治疗糖尿病，因为它能够维持血液中药物的有效浓度一个恒定的水平。

30. 发明申请

US20090042952A1 Sustained Release Composition for Oral Administration of Niacin 失效
标题翻译：烟酸口服给药缓释组合物
公开(公告)号：US20090042952A1
公开(公告)日：2009-02-12
申请号：US11569269
申请日：2005-05-27
申请人： Jong Soo Woo , Young Hun Kim
发明人： Jong Soo Woo , Young Hun Kim
IPC分类号： A61K31/4406
CPC分类号： A61K31/44 , A61K9/2027 , A61K9/2031 , A61K9/205 , A61K9/2077
摘要： A sustained release composition for oral administration of niacin, comprising niacin; a carrier for sustained release composed of a hydrophilic polymer and a hydrophobic polymer; and a pharmaceutically acceptable additive, the hydrophilic polymer being a polyethylene oxide and a natural gum, is capable of maintaining a constant release rate of niacin.
摘要翻译：口服烟酸的持续释放组合物，其包含烟酸; 由亲水性聚合物和疏水性聚合物组成的持续释放载体; 和药学上可接受的添加剂，亲水性聚合物是聚环氧乙烷和天然树胶，能够保持烟酸的恒定释放速率。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式